FDA inspection
CSPC Ouyi Pharmaceutical Co., Ltd.: FDA inspection ending May 17, 2019
FDA inspection 1091103 · Voluntary Action Indicated (VAI) · Shijiazhuang
Key facts
| Inspection ID | 1091103 |
|---|---|
| Firm | CSPC Ouyi Pharmaceutical Co., Ltd. |
| FEI number | 2000021110 |
| Address | Economic Technological Dev. Zone, 88 Yanzhi Road; Gaocheng |
| City | Shijiazhuang |
| Fiscal year | 2019 |
| Inspection end date | May 17, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data